Chapter 2. Medicare Part D's Medication Therapy Management: Shifting from Neutral to Drive
Which of the following apply to Part D MTM services?
a. They are required for all transition-of-care patients.
b. Prescriber approval is required to provide services.
c. It is required that services be face-to-face.
d. The use of telehealth is required.
e. Set selection criteria must be used to identify MTM-eligible patients.
Which of the following is true about a Part D MTM comprehensive medication review?
a. It is done on all Medicare members enrolled in a PDP or MA-PD.
b. It is done for MA-PD plans only.
c. It addresses prescriptions, non-prescriptions, herbals, and dietary supplements.
d. It requires access to medical records.
e. Low-income subsidy recipients are excluded.
Medication therapy management eligibility criteria include which of the following?
a. The number of chronic brand drugs
b. Evidence of non-adherence
d. Selected chronic disease states
e. An out-of-pocket spending limit
Which of the following statements best characterizes Part D MTM?
a. Overall member participation has been below CMS expectations.
b. Part D MTM has been proven to improve member outcomes.
c. ACOs are required to provide Part D MTM to all members.
d. Plans have no flexibility in choosing Part D MTM eligibility criteria.
e. Prescribers are prohibited from conducting Part D MTM.
Unanswered questions for Part D MTM include which of the following?
a. What information and data are useful for enhancing beneficiary awareness of MTM programs and services?
b. What is the best method for evaluating the quality of an interactive, person-to-person comprehensive medication review (CMR) and other interventions?
c. Which Part D MTM program eligibility criteria are most useful to beneficiaries in selecting a health plan?
d. Which beneficiaries may derive ...